nortriptyline / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 72 Diseases   9 Trials   9 Trials   809 News 


«12345678910»
  • ||||||||||  clomipramine / Generic mfg., imipramine / Generic mfg., nortriptyline / Generic mfg.
    Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study) (08. Room Passy) -  Mar 2, 2023 - Abstract #EPA2023EPA_294;    
    Although we were not able to demonstrate that genotype-informed dosing leads to a significantly better response, we conclude that pharmacogenetics can contribute to the optimization of pharmacological treatment. Future research may focus on subgroups for which pharmacogenetics may be of great value, such as specific antidepressants or patients with an abnormal pharmacogenetic profile.
  • ||||||||||  nortriptyline / Generic mfg.
    Journal:  Stopping the fat: Repurposing an antidepressant for cancer treatment. (Pubmed Central) -  Feb 3, 2023   
    Med.https://doi.org/10.1084/jem.20221316) describe the role of the tricyclic antidepressant nortriptyline in inhibition of fatty acid uptake. Nortriptyline promotes cell acidification and suppresses macropinocytosis, providing a link between fatty acid uptake and tumor progression.
  • ||||||||||  Movantik (naloxegol) / AstraZeneca, RedHill, Kyowa Kirin
    CYP2C19 Metabolism in Peptic Ulcer Disease (Sancy – Hilton Antwerp Old Town) -  Jan 21, 2023 - Abstract #BWG2023BWG_145;    
    The patient denied taking any non-steroidal anti-inflammatory drugs (NSAIDs). Further laboratory work-up showed elevated fasting gastrin of 975 pg/mL (normal 1000 pg/mL (in the presence of low gastric pH) are often cited as a diagnostic criterion for ZES, up to 66% of patients with ZES have gastrin levels
  • ||||||||||  pregabalin / Generic mfg., amitriptyline / Generic mfg., nortriptyline / Generic mfg.
    Journal:  Effect of Information Intervention on Prescribing Practice for Neuropathic Pain in Older Patients: A Nationwide Register-Based Study. (Pubmed Central) -  Jan 13, 2023   
    Further laboratory work-up showed elevated fasting gastrin of 975 pg/mL (normal 1000 pg/mL (in the presence of low gastric pH) are often cited as a diagnostic criterion for ZES, up to 66% of patients with ZES have gastrin levels Findings of the study suggest that personal information intervention was an effective policy tool for nudging physicians to reduce prescribing of potentially inappropriate medicines, whereas the reduction in prescribing was not accompanied by improvements or adverse effects in patients' health.
  • ||||||||||  Trial completion date, Trial primary completion date:  Treatment of Tinnitus With Migraine Medications (clinicaltrials.gov) -  Jan 9, 2023   
    P4,  N=150, Recruiting, 
    Therefore, standardized randomized controlled trials with large samples were needed to critically assess the effectiveness of these drugs in treating CIPN in the future. Trial completion date: Sep 2022 --> Dec 2023 | Trial primary completion date: Sep 2022 --> Dec 2023
  • ||||||||||  nortriptyline / Generic mfg.
    Journal:  Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition. (Pubmed Central) -  Dec 16, 2022   
    Furthermore, nortriptyline alone or in combination with ND-646, a selective ACC1/2 inhibitor, significantly repressed tumor growth, lipogenesis, and hepatic steatosis in mice. Therefore, we show that cells actively take up fatty acids through macropinocytosis, and we provide a potential strategy suppressing tumor growth, lipogenesis, and hepatic steatosis through controlling the cellular level of fatty acids.
  • ||||||||||  nortriptyline / Generic mfg.
    Trial completion date, Trial primary completion date:  Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (clinicaltrials.gov) -  Dec 5, 2022   
    P2,  N=400, Recruiting, 
    The methods were applied to determine TCAs in tap, lake, and stream water samples and the accuracy was attested by addition and recovery tests (86.7-116.0%), with determined nortriptyline ranging from 0.48 to 0.52 μg L in lake water samples. Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Oct 2022 --> Oct 2023
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Journal:  Refractory Headaches. (Pubmed Central) -  Nov 9, 2022   
    There are no guidelines for the treatment of NDPH, but options include a short course of steroids, nerve blocks, topiramate, nortriptyline, gabapentin, CGRP monoclonal antibodies, and onabotulinumtoxinA. The persistence of headache 3 months after SARS-CoV2 infection is a predictor of poor prognosis.
  • ||||||||||  perphenazine / Generic mfg., nortriptyline / Generic mfg.
    Journal:  Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote. (Pubmed Central) -  Nov 4, 2022   
    The combined release of both compounds in the brain offers several advantages over the current OP poisoning treatment protocol: improved efficacy and safety profile (where the inhibitory properties of GABA are expected to counteract the anticholinergic cognitive adverse effects of benactyzine) and enhanced chemical stability compared to benactyzine alone. We present here preliminary results of animal studies, showing promising results with early gabactyzine administration.
  • ||||||||||  nortriptyline / Generic mfg., escitalopram / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date:  ADepT-PD: Antidepressants Trial in Parkinson's Disease (clinicaltrials.gov) -  Nov 4, 2022   
    P3,  N=408, Recruiting, 
    We present here preliminary results of animal studies, showing promising results with early gabactyzine administration. Not yet recruiting --> Recruiting | Trial completion date: Dec 2022 --> Apr 2023 | Trial primary completion date: Feb 2022 --> Jan 2023
  • ||||||||||  lidocaine topical / Generic mfg., nortriptyline / Generic mfg.
    Clinical, Journal:  Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe). (Pubmed Central) -  Oct 28, 2022   
    P2
    This work is supported by the R01 HD096331 awarded to Drs. Nackley, Rapkin, Geller and Carey by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).Key messagesPeripheral lidocaine and oestradiol and centrally-targeted nortriptyline medications are used for the treatment of pain in women with VBD, but there is a lack of data from well-powered RCTs.This two-by-two factorial RCT will test the efficacy of these medications in VBD subtypes characterized by distinct clinical characteristics and biomarker profiles.We hope that results will provide clinicians with scientific evidence of therapeutic efficacy in distinct VBD subtypes in an effort to direct and optimize treatment approaches.
  • ||||||||||  nortriptyline / Generic mfg.
    Journal:  Graphene-enhanced hybrid terahertz metasurface sensor for ultrasensitive nortriptyline sensing and detection. (Pubmed Central) -  Oct 26, 2022   
    But no significant change is observed from the samples without graphene as a comparative experiment, which demonstrates that the presence of graphene greatly enhances the bonding to the drug molecules and improves the sensing sensitivity. This metasurface sensor has the advantages of high sensitivity, fast detection speed, label-free and steady properties, which has potential applications in the fields of trace molecular sensing and disease diagnosis.
  • ||||||||||  nortriptyline / Generic mfg.
    Journal:  A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. (Pubmed Central) -  Oct 14, 2022   
    Furthermore, in vivo proof-of-concept was obtained, demonstrating CADosome-mediated mRNA delivery in the corneal epithelial cells of rabbit eyes, which could pave the way for future applications in ophthalmology. Based on our results, the co-formulation of CADs, helper lipids and mRNA into lipid-based nanocarriers is proposed as a versatile and straightforward approach for the rational development of drug combination therapies.
  • ||||||||||  Chantix (varenicline) / Pfizer
    Rethinking pharmacotherapy in smoking cessation (Poster area [ONLINE]) -  Oct 13, 2022 - Abstract #ECNP2022ECNP_1421;    
    Current guidelines recommend a combination of behavioral support and pharmacologic therapy, with nicotine replacement therapy products, varenicline and bupropion being considered the first-line agents...Recurring to the PubMed database, we focused on articles published in the last decade and their included reference lists for additional information, including meta-analysis, systematic reviews and randomized clinical trials.Previous investigations have presented two second-line medications: nortriptyline, a tricyclic antidepressant with some evidence that aids smoking cessation when compared with placebo, and cytisine, a partial agonist of the α4β2 nicotinic acetylcholine receptor, similar to varenicline, that has been marketed in central and eastern Europe as an aid in the clinical management of smoking cessation for decades...Adding to this, recent reports on in vitro cytisine’s cardiotoxicity and its most common adverse reactions, such as nausea, vomiting, dyspepsia, upper abdominal pain and dry mouth must also be taken in consideration.In order to present cytisine as a valid first-line alternative to varenicline, more clinical studies with different scientific approaches are required to fully understand it’s safety and tolerability. Nonetheless, there’s already promising evidence published that could lead to changes in current guidelines for pharmacological therapy of smoking cessation in the future.
  • ||||||||||  Journal, Adverse events:  Reconsideration of the Benefits of Pharmacological Interventions for the Attenuation of the Cognitive Adverse Effects of Electroconvulsive Therapy. (Pubmed Central) -  Oct 12, 2022   
    Important findings were that acetylcholinesterase inhibitors, ketamine, memantine, and liothyronine were associated with improved global cognitive functioning at 1-14 days post-ECT...Meta-analysis was not possible for the remaining interventions, including piracetam, melatonin, pemoline, nortriptyline, herbal agents, drugs acting on the cortisol pathway, opioid receptor antagonists, l-tryptophan, vasopressin analogs, calcium channel blockers, and others; in individual RCTs, some of these interventions attenuated some cognitive measures as some time points after ECT...Future research should study such clinically meaningful outcomes (rather than laboratory tests), using pharmacologic interventions, perhaps in combination, for ECT procedures that are associated with higher cognitive AE burden. A risk is that whatever attenuates ECT-induced cognitive AEs may also attenuate ECT-related therapeutic benefits.
  • ||||||||||  Trudhesa (dihydroergotamine mesylate intranasal) / Impel NeuroPharma
    Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications () -  Sep 19, 2022 - Abstract #PAINWeek2022PAINWeek_190;    
    Safety measures were similar in patients who did or did not use concomitant migraine preventive medications over the 24-week treatment period. Results from this post hoc analysis suggest that INP104 may be an effective and well-tolerated acute medication for migraine in patients who are concurrently using preventive therapies and need effective therapy for acute episodes of migraine despite being on prevention.
  • ||||||||||  Chantix (varenicline) / Pfizer
    Review, Journal:  Does Smoking Affect OSA? What about Smoking Cessation? (Pubmed Central) -  Sep 13, 2022   
    However, there are limited data on other smoking cessation medications as bupropion, varenicline, nortriptyline, clonidine, and cytisine. The aim of this review was to explore the current evidence on the association between smoking and OSA, to evaluate if smoking cessation affects OSA, and to investigate the possible effects of different pharmacologic strategies offered for smoking cessation on OSA.
  • ||||||||||  nortriptyline / Generic mfg.
    Journal:  Drug-repositioning indicates a way to conquest corticosteroid-insensitivity (Pubmed Central) -  Sep 10, 2022   
    Calcium-channel blocker saves lung function in patients with asthma in long-term observation. DR promises us to find cheap and safe options to treat difficult asthma by inhibiting specific intracellular signaling pathways.
  • ||||||||||  nortriptyline / Generic mfg.
    Trial completion date, Trial primary completion date:  PeCon: Pediatric Concussion Outcomes (clinicaltrials.gov) -  Aug 18, 2022   
    P4,  N=100, Enrolling by invitation, 
    This work illustrates that with vDMS, the LC mobile phase composition can be used to tune the ion mobility separation and to improve assay selectivity without additional hardware. Trial completion date: Aug 2022 --> Aug 2025 | Trial primary completion date: Feb 2022 --> Feb 2025
  • ||||||||||  Chantix (varenicline) / Pfizer
    Journal:  Revised Guidelines for smoking cessation in New Zealand, 2021. (Pubmed Central) -  Jul 23, 2022   
    The guidelines will assist healthcare professionals in providing evidence-based smoking cessation support to people who smoke. To be effective and equitable, the ABC model requires organisational commitment, integration into routine practice, and increased attention to the upstream determinants of smoking and quitting.
  • ||||||||||  nortriptyline / Generic mfg., escitalopram / Generic mfg.
    Journal:  COVID-19 Prognosis in Association with Antidepressant Use. (Pubmed Central) -  Jul 10, 2022   
    This study revealed an association between antidepressants and COVID-19 prognosis. SSRIs were significantly associated with a lower risk of severe outcomes, whereas TCAs were related to the poor prognosis of COVID-19.
  • ||||||||||  nortriptyline / Generic mfg., propranolol / Generic mfg.
    Journal:  Effects of aerobic exercise and progressive muscle relaxation on migraine. (Pubmed Central) -  Jul 2, 2022   
    SSRIs were significantly associated with a lower risk of severe outcomes, whereas TCAs were related to the poor prognosis of COVID-19. Prophylactic medicine, aerobic exercises and progressive muscle relaxation, when used together, were found to be effective means of intervention for migraine.
  • ||||||||||  Review, Journal:  Diabetes: how to manage diabetic peripheral neuropathy. (Pubmed Central) -  Jul 2, 2022   
    Even with the current treatment options, people are commonly prescribed less than the recommended dose of medications, leading to poor management of DPN symptoms and treatment discontinuation. By keeping up with the latest therapy algorithms and treatment options, healthcare professionals can improve the care for people with DPN.
  • ||||||||||  venlafaxine / Generic mfg., desipramine / Generic mfg., nortriptyline / Generic mfg.
    Biomarker, Clinical, Retrospective data, Review, Journal:  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment. (Pubmed Central) -  Jun 29, 2022   
    In all patients, recent findings advocate that optimization of dopamine replacement therapy and evaluation of deep brain stimulation of the subthalamic nucleus to improve motor symptoms represents an important first step, in addition to physical activity. Overall, this review indicates that increasing understanding of neurobiological changes help to implement a roadmap of tailored interventions for patients with PD and depression, depending on the stage and comorbid symptoms underlying PD subtypes and their prognosis.
  • ||||||||||  Review, Journal:  Menopause and Sleep Disorders. (Pubmed Central) -  Jun 22, 2022   
    Hormone replacement therapy presently lacks concrete evidence to be used in menopausal women for sleep disorder. Sleep hygiene practices, self-hypnosis, meditation, and exercise play a very important role.
  • ||||||||||  nortriptyline / Generic mfg., escitalopram / Generic mfg.
    Clinical, Journal:  A Randomized Clinical Trial Comparing Two Treatment Strategies, Evaluating the Meaningfulness of HAM-D Rating Scale in Patients With Major Depressive Disorder. (Pubmed Central) -  Jun 22, 2022   
    Evaluation of both the absolute HAM-D scores and four factors derived from the HAM-D (depressed mood, sleep, psychic and somatic anxiety and suicidal ideation) revealed that the latter showed a greater promise in gauging the anti-depressant responses. The study confirms the assumption that while both drugs may improve several items on the HAM-D scale, the overall protocol may fall short of addressing the symptoms diversity in MDD and thus the analysis of factor (s) in question might be more relevant and meaningful.